uBriGene at AASCP 2026
October 2, 2026
uBriGene Biosciences, a cell and gene therapy–focused CRDMO, will exhibit at the AASCP 2026 Fall Scientific Sessions, taking place October 2–4 at the Hyatt Regency Miami. At Booth #3, uBriGene will connect with physicians, researchers, and industry professionals advancing regenerative medicine, stem cell therapies, and emerging cellular applications.
The AASCP 2026 Fall Scientific Sessions brings together professionals working across regenerative medicine and stem cell research, with discussions spanning tissue regeneration, cellular therapies, clinical applications, ethical considerations, and developments shaping the field.
For uBriGene, the event provides an opportunity to engage directly with the regenerative medicine community, exchange perspectives on emerging therapeutic approaches, and explore how innovative technologies and scalable manufacturing capabilities can support the path from research to clinical application.
At Booth #3, uBriGene will highlight its capabilities in cGMP-grade MSCs, MSC- and iPSC-derived exosomes/extracellular vesicles, and RNA-LNP iPSC reprogramming, alongside its broader expertise in advanced cell and gene therapy development and manufacturing.
These capabilities support uBriGene’s mission to accelerate advanced therapy development from concept to commercialization through client-centric collaboration, innovative platforms, scalable processes, and quality-focused manufacturing.
The event also creates opportunities for organizations exploring new regenerative medicine programs or seeking development and manufacturing expertise to connect directly with uBriGene’s scientific and commercial teams.
Connect with uBriGene at AASCP 2026
Attendees are invited to visit Booth #3 during the AASCP 2026 Fall Scientific Sessions to discuss regenerative medicine, stem cell, MSC, exosome, iPSC, and other advanced therapy programs.
Organizations interested in exploring potential collaboration or discussing a specific development or manufacturing program can schedule a one-on-one meeting with the uBriGene team in advance through the Contact us.
uBriGene looks forward to connecting with the regenerative medicine community in Miami and contributing to conversations shaping the next generation of advanced therapies.